Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 128-132

  Mori, Masaki ^a   Mimori, Koshi ^a   Ueo, Hiroaki ^a   Tsuji, Koichi ^a   Shiraishi, Takeshi ^a   Barnard, Graham F ^a   Sugimachi, Keizo ^a   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MESSENGER RNA;

ARTICLE; BLOOD; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CARCINOMA CELL; CONTROLLED STUDY; GASTROINTESTINAL CARCINOMA; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031972653     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.128     Document Type: Article

References (26)

1. Hayashi N, Ito I, Yanagisawa A, et al: Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 345:1257-1259, 1995
2. Schoenfeld A, Luqmani Y, Sinnett HD, et al: Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients. Br J Cancer 74:1639-1642, 1996
3. Noguchi S, Aihara T, Motomura K, et al: Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction. Cancer 78:1235-1240, 1996
4. Mellado B, Colomer D, Castel T, et al: Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis. J Clin Oncol 14:2091-2097, 1996
5. Kunter U, Buer J, Probst M, et al: Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88:590-594, 1996
6. Burchill SA, Bradbury MF, Pittman K, et al: Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 71:278-281, 1995
7. Hardingham JE, Kotasek D, Sage RE, et al: Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med 1:789-794, 1995
8. Datta YH, Adams PT, Drobyski WR, et al: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482, 1994
9. Ghossein RA, Scher HI, Gerald WL, et al: Detection of circulating tumor cells in patients with localized and metastatic prostate carcinomas: clinical implications. J Clin Oncol 13:1195-1200, 1995
10. Sun Y, Lin J, Katz AE, et al: Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples. Cancer Res 57:18-23, 1997
11. Soeth E, Roder C, Juhl H, et al: The detection of disseminated tumor cells in bone marrow from colorectal cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 69:278-282, 1996
12. Fields KK, Elfenbein GJ, Trudeau WL, et al: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14:1868-1876, 1996
13. Moscinski LC, Trudeau WL, Fields KK, et al: High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 5:173-180, 1996
14. Kelly KM, Womer RB, Barr FG: Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method. Cancer 78:1320-1327, 1996
15. Sidransky D, Von Eschenbach A, Tsai YC, et al: Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706-709, 1991
16. Sidransky D, Tokino T, Hamilton SR, et al: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256:102-105, 1992
17. Mori M, Mimori K, Inoue H, et al: Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 55:3417-3420, 1995
18. Mori M, Mimori K, Ueo H, et al: Molecular detection of circulating solid carcinoma cells in the peripheral blood: The concept of early systemic disease. Int J Cancer 68:739-743, 1996
19. Gerhard M, Juhl H, Kalthoff H, et al: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12:725-729, 1994
20. Mori M, Kakeji Y, Adachi Y, et al: The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer. Surgery 113:683-690, 1993
21. Chen XQ, Stroun M, Magnenat JL, et al: Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nature Med 2:1033-1035, 1996
22. Nawroz H, Koch W, Anker P, et al: Microsatellite alterations in serum DNA of head and neck cancer patients. Nature Med 2:1035-1037, 1996
23. Glaves D, Huben R, Weiss L: Haematogenous dissemination of cells from human renal adenocarcinoma. Br J Cancer 54:32-35, 1988
24. Ghossein RA, Rosai J: Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78:10-16. 1996
25. Fidler I: The biology of human cancer metastasis. Acta Oncol 30:669-675, 1991
26. Talmadge J, Fidler I: Cancer metastasis is selective or random depending on the parent tumor population. Nature 297:593-594, 1987